3.21.1 html 122 324 1 false 50 0 false 7 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets (unaudited) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (unaudited) Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity/Deficit (Unaudited) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity/Deficit (Unaudited) Statements 5 false false R6.htm 100050 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity/Deficit (Unaudited) (Parenthetical) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitUnauditedParenthetical Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity/Deficit (Unaudited) (Parenthetical) Statements 6 false false R7.htm 100060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 100070 - Disclosure - Nature of Business and Basis of Presentation Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureNatureOfBusinessAndBasisOfPresentation Nature of Business and Basis of Presentation Notes 8 false false R9.htm 100080 - Disclosure - Summary of significant accounting Policies Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of significant accounting Policies Notes 9 false false R10.htm 100090 - Disclosure - Fair Value Measurements Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 100100 - Disclosure - Supplemental Balance Sheet Information Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureSupplementalBalanceSheetInformation Supplemental Balance Sheet Information Notes 11 false false R12.htm 100110 - Disclosure - License and collaboration agreements Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureLicenseAndCollaborationAgreements License and collaboration agreements Notes 12 false false R13.htm 100120 - Disclosure - Government Grant Funding and Potential Repayment Commitments Under Recoverable Cash Advance Grants (RCAs) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureGovernmentGrantFundingAndPotentialRepaymentCommitmentsUnderRecoverableCashAdvanceGrantsRcas Government Grant Funding and Potential Repayment Commitments Under Recoverable Cash Advance Grants (RCAs) Notes 13 false false R14.htm 100130 - Disclosure - Stockholders??? equity Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureStockholdersEquity Stockholders??? equity Notes 14 false false R15.htm 100140 - Disclosure - Stock-based compensation Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureStockBasedCompensation Stock-based compensation Notes 15 false false R16.htm 100150 - Disclosure - Commitments and Contingencies Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 100160 - Disclosure - Related party transactions Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureRelatedPartyTransactions Related party transactions Notes 17 false false R18.htm 100170 - Disclosure - Net Loss Per Share Attributable to Common Stock Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStock Net Loss Per Share Attributable to Common Stock Notes 18 false false R19.htm 100180 - Disclosure - Subsequent Events Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 19 false false R20.htm 100190 - Disclosure - Summary of significant accounting policies (Policies) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of significant accounting policies (Policies) Policies 20 false false R21.htm 100200 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureFairValueMeasurements 21 false false R22.htm 100210 - Disclosure - Supplemental Balance Sheet Information (Tables) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureSupplementalBalanceSheetInformationTables Supplemental Balance Sheet Information (Tables) Tables http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureSupplementalBalanceSheetInformation 22 false false R23.htm 100220 - Disclosure - Government Grant Funding and Potential Repayment Commitments Under Recoverable Cash Advance Grants (RCAs) (Tables) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureGovernmentGrantFundingAndPotentialRepaymentCommitmentsUnderRecoverableCashAdvanceGrantsRcasTables Government Grant Funding and Potential Repayment Commitments Under Recoverable Cash Advance Grants (RCAs) (Tables) Tables http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureGovernmentGrantFundingAndPotentialRepaymentCommitmentsUnderRecoverableCashAdvanceGrantsRcas 23 false false R24.htm 100230 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables 24 false false R25.htm 100240 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingencies 25 false false R26.htm 100250 - Disclosure - Net Loss Per Share Attributable to Common Stock (Tables) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockTables Net Loss Per Share Attributable to Common Stock (Tables) Tables http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStock 26 false false R27.htm 100260 - Disclosure - Nature of Business and Basis of Presentation - Additional Information (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails Nature of Business and Basis of Presentation - Additional Information (Details) Details 27 false false R28.htm 100270 - Disclosure - Fair Value Measurements - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Details 28 false false R29.htm 100280 - Disclosure - Fair Value Measurements - Summary of Fair Value of Series B Preferred Stock Tranche Rights Liability (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFairValueOfSeriesBPreferredStockTrancheRightsLiabilityDetails Fair Value Measurements - Summary of Fair Value of Series B Preferred Stock Tranche Rights Liability (Details) Details 29 false false R30.htm 100290 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 30 false false R31.htm 100300 - Disclosure - Fair Value Measurements - Summary of Changes in Level 3 Liabilities Measures at Fair Value on a Recurring Basis (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfChangesInLevel3LiabilitiesMeasuresAtFairValueOnRecurringBasisDetails Fair Value Measurements - Summary of Changes in Level 3 Liabilities Measures at Fair Value on a Recurring Basis (Details) Details 31 false false R32.htm 100310 - Disclosure - Supplemental Balance Sheet Information - Schedule of Property and Equipment, Net (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfPropertyAndEquipmentNetDetails Supplemental Balance Sheet Information - Schedule of Property and Equipment, Net (Details) Details 32 false false R33.htm 100320 - Disclosure - Supplemental Balance Sheet Information - Additional Information (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureSupplementalBalanceSheetInformationAdditionalInformationDetails Supplemental Balance Sheet Information - Additional Information (Details) Details 33 false false R34.htm 100330 - Disclosure - Supplemental Balance Sheet Information - Schedule of Accrued Expenses (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedExpensesDetails Supplemental Balance Sheet Information - Schedule of Accrued Expenses (Details) Details 34 false false R35.htm 100340 - Disclosure - License and collaboration agreements - Additional Information (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsAdditionalInformationDetails License and collaboration agreements - Additional Information (Details) Details 35 false false R36.htm 100350 - Disclosure - Government Grant Funding and Potential Repayment Commitments Under Recoverable Cash Advance Grants (RCAs) - Additional Information (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureGovernmentGrantFundingAndPotentialRepaymentCommitmentsUnderRecoverableCashAdvanceGrantsRcasAdditionalInformationDetails Government Grant Funding and Potential Repayment Commitments Under Recoverable Cash Advance Grants (RCAs) - Additional Information (Details) Details http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureGovernmentGrantFundingAndPotentialRepaymentCommitmentsUnderRecoverableCashAdvanceGrantsRcasTables 36 false false R37.htm 100360 - Disclosure - Government Grant Funding and Potential Repayment Commitments Under Recoverable Cash Advance Grants (RCAs) - Schedule of Activity for Grant Programs (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureGovernmentGrantFundingAndPotentialRepaymentCommitmentsUnderRecoverableCashAdvanceGrantsRcasScheduleOfActivityForGrantProgramsDetails Government Grant Funding and Potential Repayment Commitments Under Recoverable Cash Advance Grants (RCAs) - Schedule of Activity for Grant Programs (Details) Details http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureGovernmentGrantFundingAndPotentialRepaymentCommitmentsUnderRecoverableCashAdvanceGrantsRcasTables 37 false false R38.htm 100370 - Disclosure - Stockholders' equity - Additional Information (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails Stockholders' equity - Additional Information (Details) Details 38 false false R39.htm 100380 - Disclosure - Stock-based compensation - Additional Information (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails Stock-based compensation - Additional Information (Details) Details 39 false false R40.htm 100390 - Disclosure - Stock-based compensation - Summary of Stock-Based Compensation Expense (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails Stock-based compensation - Summary of Stock-Based Compensation Expense (Details) Details 40 false false R41.htm 100400 - Disclosure - Stock-based compensation - Summary of Stock Options Activity (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionsActivityDetails Stock-based compensation - Summary of Stock Options Activity (Details) Details 41 false false R42.htm 100410 - Disclosure - Stock-based compensation - Schedule of Fair Value Assumptions for Stock Options Granted (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueAssumptionsForStockOptionsGrantedDetails Stock-based compensation - Schedule of Fair Value Assumptions for Stock Options Granted (Details) Details 42 false false R43.htm 100420 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 43 false false R44.htm 100430 - Disclosure - Commitments and Contingencies - Schedule Of Lease Terms And Discount Rate (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermsAndDiscountRateDetails Commitments and Contingencies - Schedule Of Lease Terms And Discount Rate (Details) Details 44 false false R45.htm 100440 - Disclosure - Commitments and Contingencies -Schedule Of Cash Flow And Other Information (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfCashFlowAndOtherInformationDetails Commitments and Contingencies -Schedule Of Cash Flow And Other Information (Details) Details 45 false false R46.htm 100450 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancelable Operating Leases (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancelable Operating Leases (Details) Details 46 false false R47.htm 100470 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 47 false false R48.htm 100480 - Disclosure - Net Loss Per Share Attributable to Common Stock - Schedule of Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockScheduleOfCommonStockEquivalentsExcludedFromCalculationOfDilutedNetLossPerShareDetails Net Loss Per Share Attributable to Common Stock - Schedule of Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share (Details) Details 48 false false R49.htm 100490 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://www.iteostherapeutics.com/20210331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 49 false false All Reports Book All Reports itos-20210331.xml itos-20210331.xsd itos-20210331_cal.xml itos-20210331_def.xml itos-20210331_lab.xml itos-20210331_pre.xml http://xbrl.sec.gov/country/2020-01-31 http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://xbrl.sec.gov/stpr/2018-01-31 true true